With big pharma in many cases absent from the game, biotech entered the field.

FORBES: Magazine Article

As analysts at Credit Suisse also note, there is a scarcity of pure play antibody companies, and Regeneron is now the largest biotech player focused almost exclusivity in this field.

FORBES: The Logic Of Biologics - Is Regeneron The Next Genentech?

Some of the world's biggest drug and biotech firms are entering the once-neglected field, including Novartis, Biogen Idec and Merck.

FORBES: Magazine Article

Chris Somerville, the Stanford plant geneticist who has been tapped to run the big project, is himself the co-founder of two biotech firms that will work in the same field as the institute.

FORBES: BP's Biotech Bet

Most of the people who were copied are somehow linked to the biotech industry, and many are linked to the especially controversial field of embryonic stem cell research.

FORBES: Social Media

In many areas, such as semiconductors, biotech and even software, individual inventors have all but abandoned the field as being too expensive for them.

FORBES: The smother of invention

For private equity funds that means treading onto someone else's turf rather than having created the playing field themselves, as they did in the tech and biotech booms.

FORBES: How Private Equity Plays Green

Then they invariably overlook the strengths of also-ran firms, which field large sales forces and often buy or strike alliances with biotech and other drug outfits that lack marketing muscle but create potential breakthrough products.

FORBES: Drugs of Choice